Search results for "Pregnancy complications"

showing 10 items of 490 documents

Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy.

2013

Although most of the women (69.4%) had a normal BMI at start of pregnancy, only 37% had an adequate weight gain during pregnancy. Inadequate body weight gain was more common (44.8%) than excessive weight gain (18.2%), but 40% of overweight women and 50% of obese women had an excessive weight gain in pregnancy, with about 9% of the women in these categories gaining >18 kg during pregnancy (Table 1). Only 1.9% of the women had a vaginal delivery; elective and nonelective cesarean deliveries accounted for 81.3% and 16.7% of deliveries, respectively. Compared to underweight/normal women, overweight/obese women had similar occurrences of preterm delivery (23.4% vs 22.7%, P = .871), significantly…

Microbiology (medical)medicine.medical_specialtyantiretroviral therapyMEDLINEHuman immunodeficiency virus (HIV)HIV Infectionsbody mass indexmedicine.disease_causeSettore MED/17 - MALATTIE INFETTIVEBody Mass IndexBMIBody Mass Index; weight gain; HIV-1; PregnancyPregnancyMedicineHumansHIV infection; pregnancy; body mass indexPregnancy Complications InfectiousPregnancybusiness.industryObstetricsCesarean SectionInfectiousPregnancy OutcomeHIVweight gainmedicine.diseaseHIV infectionPregnancy ComplicationsInfectious DiseasesItalyNational studyHIV-1Femalepregnancymedicine.symptombusinessWeight gainBody mass index
researchProduct

Is it possible to predict late antepartum stillbirth by means of cerebroplacental ratio and maternal characteristics?

2019

Objective: To examine the potential value of fetal ultrasound and maternal characteristics in the prediction of antepartum stillbirth after 32 weeks’ gestation. Methods: This was a retrospective multicenter study in Spain. In 29 pregnancies, umbilical artery pulsatility index (UA PI), middle cerebral artery pulsatility index (MCA PI), cerebroplacental ratio (CPR), estimated fetal weight (EFW), and maternal characteristics were recorded within 15 days prior to a stillbirth. The values of UA PI, MCA PI, and CPR were converted into multiples of the normal median (MoM) for gestational age and the EFW was expressed as percentile according to a Spanish reference range for gestational age. Data fr…

Middle Cerebral Arterymedicine.medical_specialtyFetal middle cerebral artery DopplerCerebroplacental ratioGestational AgeUmbilical artery dopplerUltrasonography PrenatalUmbilical Arteries03 medical and health sciencesFetal hemodynamics0302 clinical medicinePregnancyUmbilical artery DopplermedicineHumans030212 general & internal medicinereproductive and urinary physiologyRetrospective StudiesFetus030219 obstetrics & reproductive medicineObstetricsbusiness.industryFetal growth restrictionUltrasoundObstetrics and GynecologyStillbirthfemale genital diseases and pregnancy complicationsbody regionsSpainPulsatile FlowAntepartum stillbirthembryonic structuresPediatrics Perinatology and Child Healthpopulation characteristicsFemalebusinessValue (mathematics)The Journal of Maternal-Fetal & Neonatal Medicine
researchProduct

Human papillomavirus: Its identikit and controversial role in oral oncogenesis, premalignant and malignant lesions (Review)

2007

Human papillomaviruses (HPVs) are a group of host-specific DNA viruses, with a remarkable epithelial cell specificity: they have been reported principally in the ano-genital tract, urethra, skin, larynx, tracheo-bronchial and oral mucosa. More than 100 different HPV types have been identified and classified as high (e.g. 16, 18, 31) or low (e.g. 11, 42, 36) -risk (HR and LR), based on their association with cervical carcinoma. The carcinogenic role of HR-HPV revolves mainly around two of its oncoproteins: HPV-E6 which promotes degradation of the p53 tumour suppressor gene product and HPV-E7 which modifies the pRb tumour suppressor gene product, inhibiting the activity of TGF-beta2. Since th…

Mouth neoplasmCancer ResearchOncogenebiologybusiness.industryHPV infectionvirus diseasesCancerCell cyclemedicine.diseasemedicine.disease_causebiology.organism_classificationfemale genital diseases and pregnancy complicationsstomatognathic diseasesmedicine.anatomical_structureOncologyImmunologyCancer researchMedicineOral mucosaPapillomaviridaebusinessCarcinogenesis
researchProduct

Serological prevalence of toxoplasmosis in pregnant women in Luanda (Angola): Geospatial distribution and its association with socio-demographic and …

2020

We report a study on toxoplasmosis in pregnant women in Luanda, Angola, determining the seroprevalence, geospatial distribution and its association with socio-economic features, dietary habits and hygiene and health conditions. Anti-Toxoplasma gondii IgG and IgM were quantified in serum samples of women attended at the Lucrecia Paim Maternity Hospital between May 2016 and August 2017. The IgG avidity test and qPCR assay were used for dating the primary infection. Data were collected by questionnaire after written consent, and spatial distribution was assessed through a Kernel Density Function. The potential risk factors associated with Toxoplasma infection were evaluated using bivariate and…

Multivariate analysisEpidemiologyMaternal HealthAntibodies ProtozoanMiscarriageToxoplasma GondiiSerologyGeographical LocationsMedical ConditionsPregnancySeroepidemiologic StudiesPrevalenceMedicine and Health SciencesLongitudinal StudiesProtozoansMammalsMultidisciplinaryGeographybiologyCoinfectionObstetricsLiver DiseasesQRObstetrics and GynecologyEukaryotaMiddle AgedHepatitis BPopulation SurveillanceVertebratesMedicineFemaleToxoplasmaToxoplasmosisMaternal AgeResearch ArticleAdultmedicine.medical_specialtyAdolescentScienceGastroenterology and HepatologyLower riskYoung AdultParasitic DiseasesmedicineHumansAnimalsSeroprevalenceLiver Disease and PregnancyPregnancyProtozoan Infectionsbusiness.industryOrganismsBiology and Life SciencesToxoplasma gondiimedicine.diseasebiology.organism_classificationParasitic ProtozoansToxoplasmosisPregnancy ComplicationsCross-Sectional StudiesLogistic ModelsAngolaPregnancy Complications ParasiticMedical Risk FactorsPeople and PlacesAfricaAmniotesCatsWomen's HealthbusinessZoologyPLoS ONE
researchProduct

Human parvovirus B19 infection and antiphospholipid antibodies

2007

Erythema infectiosum is the main manifestation of human parvovirus B19 infections. Further B19-related diseases commonly associated with the acute infection are flue-like symptoms, transient aplastic crisis, transient arthralgias, leukopenia and thrombocytopenia, spontaneous abortion and hydrops fetalis in pregnant women. Hepatitis, myocarditis, meningitis, encephalitis as well as pure red cell anemia may occur occasionally. In addition parvovirus B19 infections have been frequently described as cause or trigger of various forms of autoimmune diseases affecting all blood cell lines, joints, connective tissue, uvea, large and small vessels. Molecular mimicry may be one major contribution to …

MyocarditisvirusesImmunologymedicine.disease_causeAutoimmune DiseasesParvoviridae InfectionsPregnancyhemic and lymphatic diseasesHydrops fetalisParvovirus B19 HumanHumansImmunology and AllergyMedicinePregnancy Complications InfectiousAnti-neutrophil cytoplasmic antibodyHepatitisbiologybusiness.industryParvovirusvirus diseasesmedicine.diseasebiology.organism_classificationVirologyMolecular mimicryErythema InfectiosumImmunologyAntibodies AntiphospholipidFemalebusinessEncephalitisAutoimmunity Reviews
researchProduct

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

2008

AbstractThe tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cells (DCs) and the induction of primary immune responses in vivo. Sorafenib, but not sunitinib, inhibits function of DCs, characterized by reduced secretion of cytokines and expression of CD1a, major histocompatibility complex, and costimulatory molecules in response to TLR ligands as well as by their impaired ability to migrate and stimulate T-cell responses. These inhib…

NiacinamideSorafenibIndolesPyridinesImmunologyAntineoplastic AgentsApoptosisCD8-Positive T-LymphocytesPharmacologyBiologyurologic and male genital diseasesMajor histocompatibility complexT-Lymphocytes RegulatoryBiochemistryPeripheral blood mononuclear cellMiceImmune systemCell MovementIn vivoSunitinibmedicineAnimalsHumansCytotoxic T cellPyrrolesCells CulturedSunitinibPhenylurea CompoundsBenzenesulfonatesGranulocyte-Macrophage Colony-Stimulating FactorDextransDendritic CellsCell BiologyHematologySorafenibEndocytosisfemale genital diseases and pregnancy complicationsMice Inbred C57BLToll-Like Receptor 4biology.proteinCytokinesFemaleInterleukin-4Lymphocyte Culture Test MixedTyrosine kinaseCell DivisionSignal Transductionmedicine.drugBlood
researchProduct

Mild dehydration: a risk factor of urinary tract infection?

2003

Bacterial growth in the urinary tract is usually prevented by host factors including bacterial eradication by urinary and mucus flow, urothelial bactericidal activity, urinary secretory IgA, and blood group antigens in secretions which interfere with bacterial adherence. Bacterial eradication from the urinary tract is partially dependent on urine flow and voiding frequency. Therefore, it seems logical to postulate a connection between fluid intake and the risk of urinary tract infections (UTIs). However, experimental and clinical data on this subject are conflicting. Experimental studies concerning the effect of water intake on susceptibility and course of UTIs were predominantly performed …

Nutrition and DieteticsDehydrationUrinary systemDrinkingMedicine (miscellaneous)PhysiologyHost defenceHydrogen-Ion ConcentrationUrineBiologyurologic and male genital diseasesAntimicrobialMucusfemale genital diseases and pregnancy complicationsAnti-Bacterial AgentsBlood group antigensFluid intakeRisk FactorsMild dehydrationUrinary Tract InfectionsImmunologyHumansSecretory IgAEuropean Journal of Clinical Nutrition
researchProduct

TLR4 down-regulation identifies high risk HPV infection and integration in head and neck squamous cell carcinomas

2015

TLRs are main actors of the innate immune response against HPV. There are very few studies on the role of TLRs mediated HPV clearance in Head and Neck oncology. Our aim was to evaluate whether TLR4 expression identifies HPV infection and/or HR-HPV integration status in oral and oropharyngeal cancers. By immunohistochemistry we assessed TLR4 levels in OSCC/OPSCC. To detect viral integration or episomic status In situ hybridization for HPV-DNA and Pyro-sequencing techniques have been performed. The relationship between TLR4 expression with HPV infection status has been investigated. ISH HPV positive samples have reported lower levels of TLR4 intensity than negative samples (p = .002). There w…

Oncology0301 basic medicineAdultMalemedicine.medical_specialtyVirus IntegrationCellDown-RegulationIn situ hybridizationBiologyAlphapapillomavirusGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesRetrospective StudieInternal medicineCarcinomamedicineHumansVirus IntegrationIn Situ HybridizationRetrospective StudiesAgedAged 80 and overInnate immune systemGeneral Immunology and MicrobiologyHead and Neck NeoplasmAlphapapillomaviruExpression indexHPV infectionvirus diseasesMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsToll-Like Receptor 4medicine.anatomical_structure030104 developmental biologyHead and Neck NeoplasmsImmunologyDNA ViralCarcinoma Squamous CellImmunohistochemistryFemaleHuman
researchProduct

Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.

2013

Contribution over time of human papillomavirus (HPV) types in human cancers has been poorly documented. Such data is fundamental to measure current HPV vaccines impact in the years to come. We estimated the HPV type-specific distribution in a large international series of invasive cervical cancer (ICC) over 70 years prior to vaccination. Paraffin embedded ICC cases diagnosed between 1940 and 2007 were retrieved from eleven countries in Central-South America, Asia and Europe. Included countries reported to have low-medium cervical cancer screening uptake. Information on age at and year of diagnosis was collected from medical records. After histological confirmation, HPV DNA detection was per…

OncologyAdultCancer ResearchInvasive cervical cancermedicine.medical_specialtyAsiavirusesUterine Cervical NeoplasmsHPV vaccinesLogistic regressionInternal medicinemedicineHumansNeoplasm InvasivenessHuman papillomavirusEarly Detection of CancerAgedRetrospective StudiesGynecologyCervical cancerHuman papillomavirus 16Paraffin EmbeddingHuman papillomavirus 18business.industryTime trendsMedical recordvirus diseasesCentral AmericaMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsVaccinationEuropeLogistic ModelsOncologyDNA ViralFemalebusinessInternational journal of cancer
researchProduct

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicente…

2006

Abstract Background Carboplatin/paclitaxel is the chemotherapy of choice for advanced ovarian cancer, both in first line and in platinum-sensitive recurrence. Although a significant proportion of patients have some neurotoxicity during treatment, the long-term outcome of chemotherapy-induced neuropathy has been scantly studied. We retrospectively assessed the prevalence of residual neuropathy in a cohort of patients in clinical remission after first-line carboplatin/paclitaxel for advanced ovarian cancer. Methods 120 patients have been included in this study (101 participating in a multicentre phase III trial evaluating the efficacy of consolidation treatment with topotecan, and 19 treated …

OncologyAdultmedicine.medical_specialtyCancer ResearchTime Factorsendocrine system diseasesPaclitaxelmedicine.medical_treatmentlcsh:RC254-282Severity of Illness IndexCarboplatinchemistry.chemical_compoundMedian follow-upInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineGeneticsHumansAgedRetrospective StudiesOvarian NeoplasmsChemotherapybusiness.industryCancerPeripheral Nervous System DiseasesRetrospective cohort studyMiddle Agedmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCarboplatinfemale genital diseases and pregnancy complicationsClinical trialchemistryOncologyTopotecanFemalebusinessOvarian cancerTopotecanmedicine.drugResearch Article
researchProduct